Literature DB >> 2935741

Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.

M M Caramona, J V Esplugues, W Osswald.   

Abstract

FLA 668 (+) [(S)-(+)-4-amino-2, alpha-dimethylethylphenethylamine (+)-hydrogen bitartrate] selectively inhibited MAO type A in homogenates of dog saphenous vein, with a IC50 of 1 mumol/l for MAO A and greater than 1 mmol/l for MAO B. At concentrations of 1 mumol/l and higher, FLA 668(+) progressively decreased the formation of deaminated metabolites by saphenous vein strips incubated with 3H-noradrenaline, with a preferential action on DOPEG formation. Normetanephrine formation increased but this increase did not wholly compensate for the reduction in the formation of deaminated metabolites. FLA 668(+) caused increased reactivity of saphenous vein strips to noradrenaline and markedly reduced the accumulation of 3H-noradrenaline in the incubated tissue; both effects were still evident in the presence of clorgyline. After cocaine, FLA 668(+) caused no further increase in sensitivity. It is concluded that FLA 668(+) is, in the saphenous vein of the dog, a selective inhibitor of MAO type A and that it exerts a cocaine-like effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935741     DOI: 10.1007/bf00634236

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Adrenergic receptors in the veins of the dog.

Authors:  S Guimarães; W Osswald
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

2.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

3.  Occurrence and properties of monoamine oxidase in adrenergic neurons.

Authors:  B Jarrott
Journal:  J Neurochem       Date:  1971-01       Impact factor: 5.372

4.  Localization of monoamine oxidase of type A and B in blood vessels with different innervation patterns.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

Review 5.  Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects.

Authors:  W Osswald; S Guimarães
Journal:  Rev Physiol Biochem Pharmacol       Date:  1983       Impact factor: 5.545

6.  Selective inhibition by amezinium of intraneuronal monoamine oxidase.

Authors:  A Steppeler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

7.  On the mechanism of action of amezinium methylsulphate on the dog saphenous vein.

Authors:  D Araújo; M M Caramona; W Osswald
Journal:  Eur J Pharmacol       Date:  1983-06-03       Impact factor: 4.432

8.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

9.  Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.

Authors:  A L Ask; I Fagervall; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

10.  Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.

Authors:  M M Caramona; D Araújo; F Brandão
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.